BDBM168091 US9073931, E11a::US9073931, E11b

SMILES: CCCC(O)c1cnc(nc1C(F)(F)F)N1CCn2c(nc3cc(CO)c(cc23)S(C)(=O)=O)[C@H]1C(C)C

InChI Key: InChIKey=WZDFAJOVHXXHKS-ROPPNANJSA-N

Data: 4 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 168091   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Oxysterols receptor LXR-beta (Homo sapiens (Human))	BDBM168091 (US9073931, E11a | US9073931, E11b) Show SMILES CCCC(O)c1cnc(nc1C(F)(F)F)N1CCn2c(nc3cc(CO)c(cc23)S(C)(=O)=O)[C@H]1C(C)C |r| Show InChI InChI=1S/C24H30F3N5O4S/c1-5-6-18(34)15-11-28-23(30-21(15)24(25,26)27)32-8-7-31-17-10-19(37(4,35)36)14(12-33)9-16(17)29-22(31)20(32)13(2)3/h9-11,13,18,20,33-34H,5-8,12H2,1-4H3/t18?,20-/m1/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	14	-10.7	n/a	n/a	n/a	n/a	n/a	n/a	25
Vitae Pharmaceuticals, Inc. US Patent					Assay Description Compounds of the invention were assessed in a competition binding assay where different concentrations of compounds were incubated with the LXR ligan...				US Patent US9073931 (2015) BindingDB Entry DOI: 10.7270/Q26W98VC
					More data for this Ligand-Target Pair
Oxysterols receptor LXR-beta (Homo sapiens (Human))	BDBM168091 (US9073931, E11a | US9073931, E11b) Show SMILES CCCC(O)c1cnc(nc1C(F)(F)F)N1CCn2c(nc3cc(CO)c(cc23)S(C)(=O)=O)[C@H]1C(C)C |r| Show InChI InChI=1S/C24H30F3N5O4S/c1-5-6-18(34)15-11-28-23(30-21(15)24(25,26)27)32-8-7-31-17-10-19(37(4,35)36)14(12-33)9-16(17)29-22(31)20(32)13(2)3/h9-11,13,18,20,33-34H,5-8,12H2,1-4H3/t18?,20-/m1/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	23	-10.4	n/a	n/a	n/a	n/a	n/a	n/a	25
Vitae Pharmaceuticals, Inc. US Patent					Assay Description Compounds of the invention were assessed in a competition binding assay where different concentrations of compounds were incubated with the LXR ligan...				US Patent US9073931 (2015) BindingDB Entry DOI: 10.7270/Q26W98VC
					More data for this Ligand-Target Pair
Oxysterols receptor LXR-alpha (Homo sapiens (Human))	BDBM168091 (US9073931, E11a | US9073931, E11b) Show SMILES CCCC(O)c1cnc(nc1C(F)(F)F)N1CCn2c(nc3cc(CO)c(cc23)S(C)(=O)=O)[C@H]1C(C)C |r| Show InChI InChI=1S/C24H30F3N5O4S/c1-5-6-18(34)15-11-28-23(30-21(15)24(25,26)27)32-8-7-31-17-10-19(37(4,35)36)14(12-33)9-16(17)29-22(31)20(32)13(2)3/h9-11,13,18,20,33-34H,5-8,12H2,1-4H3/t18?,20-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	160	-9.26	n/a	n/a	n/a	n/a	n/a	n/a	25
Vitae Pharmaceuticals, Inc. US Patent					Assay Description Compounds of the invention were assessed in a competition binding assay where different concentrations of compounds were incubated with the LXR ligan...				US Patent US9073931 (2015) BindingDB Entry DOI: 10.7270/Q26W98VC
					More data for this Ligand-Target Pair
Oxysterols receptor LXR-alpha (Homo sapiens (Human))	BDBM168091 (US9073931, E11a | US9073931, E11b) Show SMILES CCCC(O)c1cnc(nc1C(F)(F)F)N1CCn2c(nc3cc(CO)c(cc23)S(C)(=O)=O)[C@H]1C(C)C |r| Show InChI InChI=1S/C24H30F3N5O4S/c1-5-6-18(34)15-11-28-23(30-21(15)24(25,26)27)32-8-7-31-17-10-19(37(4,35)36)14(12-33)9-16(17)29-22(31)20(32)13(2)3/h9-11,13,18,20,33-34H,5-8,12H2,1-4H3/t18?,20-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	236	-9.03	n/a	n/a	n/a	n/a	n/a	n/a	25
Vitae Pharmaceuticals, Inc. US Patent					Assay Description Compounds of the invention were assessed in a competition binding assay where different concentrations of compounds were incubated with the LXR ligan...				US Patent US9073931 (2015) BindingDB Entry DOI: 10.7270/Q26W98VC
					More data for this Ligand-Target Pair